Cargando…
Development of Fluorinated Non-Peptidic Ghrelin Receptor Ligands for Potential Use in Molecular Imaging
The ghrelin receptor (GhrR) is a widely investigated target in several diseases. However, the current knowledge of its role and distribution in the brain is limited. Recently, the small and non-peptidic compound (S)-6-(4-bromo-2-fluorophenoxy)-3-((1-isopropylpiperidin-3-yl)methyl)-2-methylpyrido[3,2...
Autores principales: | Moldovan, Rareş-Petru, Els-Heindl, Sylvia, Worm, Dennis J., Kniess, Torsten, Kluge, Michael, Beck-Sickinger, Annette G., Deuther-Conrad, Winnie, Krügel, Ute, Brust, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412352/ https://www.ncbi.nlm.nih.gov/pubmed/28379199 http://dx.doi.org/10.3390/ijms18040768 |
Ejemplares similares
-
Synthesis and Preliminary Biological Evaluation of Indol-3-yl-oxoacetamides as Potent Cannabinoid Receptor Type 2 Ligands
por: Moldovan, Rareş-Petru, et al.
Publicado: (2017) -
A 3D-QSAR model for cannabinoid receptor (CB2) ligands derived from aligned pharmacophors
por: Günther, Robert, et al.
Publicado: (2013) -
Development of cannabinoid receptor (CB 2 R) ligands for application in PET studies - where to attach the radiolabel?
por: Günther, Robert, et al.
Publicado: (2014) -
Design, Radiosynthesis and Preliminary Biological Evaluation in Mice of a Brain-Penetrant (18)F-Labelled σ(2) Receptor Ligand
por: Moldovan, Rareş-Petru, et al.
Publicado: (2021) -
Development of [(18)F]LU14 for PET Imaging of Cannabinoid Receptor Type 2 in the Brain
por: Teodoro, Rodrigo, et al.
Publicado: (2021)